title: Fos expression in rat brain during depletion-induced thirst and salt appetite.
abstract: The expression of Fos protein (Fos immunoreactivity, Fos-ir) was mapped in the brain of rats subjected to an angiotensin-dependent model of thirst and salt appetite. The physiological state associated with water and sodium ingestion was produced by the concurrent subcutaneous administration of the diuretic furosemide (10 mg/kg) and a low dose of the angiotensin-converting enzyme (ACE) inhibitor captopril (5 mg/kg; Furo/Cap treatment). The animals were killed 2 h posttreatment, and the brains were processed for Fos-ir to assess neural activation. Furo/Cap treatment significantly increased Fos-ir density above baseline levels both in structures of the lamina terminalis and hypothalamus known to mediate the actions of ANG II and in hindbrain regions associated with blood volume and pressure regulation. Furo/Cap treatment also typically increased Fos-ir density in these structures above levels observed after administration of furosemide or captopril separately. Fos-ir was reduced to a greater extent in forebrain than in hindbrain areas by a dose of captopril (100 mg/kg sc) known to block the actions of ACE in the brain. The present work provides further evidence that areas of lamina terminalis subserve angiotensin-dependent thirst and salt appetite.
authors.affiliation: Department of Psychology, University of Iowa, Iowa City, Iowa 52242-1407, USA.
authors.forename: R L
authors.initials: RL
authors.lastname: Thunhorst
authors.forename: Z
authors.initials: Z
authors.lastname: Xu
authors.forename: M Z
authors.initials: MZ
authors.lastname: Cicha
authors.forename: A M
authors.initials: AM
authors.lastname: Zardetto-Smith
authors.forename: A K
authors.initials: AK
authors.lastname: Johnson
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000378:metabolism*; D001931:Brain Mapping; D002216:Captopril / Q000008:administration & dosage; D004232:Diuretics / Q000008:administration & dosage; D005665:Furosemide / Q000008:administration & dosage; D008297:Male; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D011301:Preoptic Area / Q000378:metabolism; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism*; D051381:Rats; D013356:Subfornical Organ / Q000378:metabolism; D013894:Thirst
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004232:Diuretics; D016760:Proto-Oncogene Proteins c-fos; D005665:Furosemide; D002216:Captopril